UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+0.05%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.52B
AUM Growth
+$53.7M
(+1.5%)
Cap. Flow
-$42.8M
Cap. Flow
% of AUM
-1.22%
Top 10 Holdings %
Top 10 Hldgs %
49.92%
Holding
595
New
104
Increased
143
Reduced
92
Closed
93
Top Buys
Top Sells
Sector Composition
| 1 | Energy | 26.72% |
| 2 | Technology | 21.14% |
| 3 | Healthcare | 14.79% |
| 4 | Industrials | 8.25% |
| 5 | Materials | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Kilroy Realty
KRC
$5.02B
| $1.26M | 0.04% |
40,382
-8,343
| -17% | -$260K |
|
252
InflaRx
IFRX
$106M
| $1.26M | 0.04% |
721,768
+339,359
| +89% | +$590K |
|
253
KLA
KLAC
$121B
| $1.24M | 0.03% |
+1,500
| New | +$1.24M |
|
254
InvenTrust Properties
IVT
$2.31B
| $1.23M | 0.03% |
49,669
-9,706
| -16% | -$240K |
|
255
Axsome Therapeutics
AXSM
$6.26B
| $1.22M | 0.03% |
15,118
+6,200
| +70% | +$499K |
|
|
SWTX
256
DELISTED
SpringWorks Therapeutics
SWTX
| $1.21M | 0.03% |
32,214
-15,036
| -32% | -$566K |
|
257
enVVeno Medical
NVNO
$15.2M
| $1.21M | 0.03% |
230,790
+4,482
| +2% | +$23.5K |
|
258
Lionsgate Studios Corp.
LION
$1.77B
| $1.21M | 0.03% |
+150,000
| New | +$1.21M |
|
|
ITCI
259
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.16M | 0.03% |
+17,000
| New | +$1.16M |
|
260
Dyne Therapeutics
DYN
$1.96B
| $1.16M | 0.03% |
32,944
-181
| -0.5% | -$6.39K |
|
|
FNA
261
DELISTED
Paragon 28, Inc.
FNA
| $1.14M | 0.03% |
166,743
+47,098
| +39% | +$322K |
|
262
Evolv Technologies
EVLV
$1.41B
| $1.13M | 0.03% |
444,123
-362,500
| -45% | -$924K |
|
263
Globant
GLOB
$2.72B
| $1.13M | 0.03% |
+6,317
| New | +$1.13M |
|
264
Crinetics Pharmaceuticals
CRNX
$3.28B
| $1.13M | 0.03% |
25,121
+19,100
| +317% | +$855K |
|
265
StoneCo
STNE
$4.6B
| $1.12M | 0.03% |
+93,614
| New | +$1.12M |
|
266
Annexon
ANNX
$249M
| $1.12M | 0.03% |
228,277
-20,000
| -8% | -$98K |
|
267
Alchemy Investments Acquisition Corp 1
ALCY
$49.1M
| $1.11M | 0.03% |
103,486
| – | – |
|
268
Mersana Therapeutics
MRSN
$33.3M
| $1.09M | 0.03% |
21,772
+4,400
| +25% | +$221K |
|
269
Alcon
ALC
$39.5B
| $1.09M | 0.03% |
12,254
+6,200
| +102% | +$552K |
|
270
Haymaker Acquisition Corp 4
HYAC
| $1.09M | 0.03% |
103,486
| – | – |
|
271
Alphatec Holdings
ATEC
$2.42B
| $1.08M | 0.03% |
103,771
-19,050
| -16% | -$199K |
|
272
Cullinan Oncology
CGEM
$403M
| $1.08M | 0.03% |
61,975
+2,623
| +4% | +$45.7K |
|
273
KALA BIO
KALA
$107M
| $1.05M | 0.03% |
147,554
+75,000
| +103% | +$532K |
|
|
MFA
274
MFA Financial
MFA
$1.07B
| $1.04M | 0.03% |
97,421
-12,379
| -11% | -$132K |
|
275
ON Semiconductor
ON
$19.9B
| $1.03M | 0.03% |
15,000
-12,500
| -45% | -$857K |
|